 | • レポートコード：MRC2Q12-16756 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、細胞毒性検査のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 細胞毒性検査のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞毒性検査の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 細胞毒性検査のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの細胞毒性検査の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の細胞毒性検査の売上および2028年までの予測に焦点を当てています。 細胞毒性検査のグローバル主要企業には、Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongweiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 細胞毒性検査市場は、タイプとアプリケーションによって区分されます。世界の細胞毒性検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他 【アプリケーション別セグメント】 医療機器、医療用付属品、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 細胞毒性検査製品概要 - タイプ別市場（溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他） - アプリケーション別市場（医療機器、医療用付属品、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の細胞毒性検査販売量予測2017-2028 - 世界の細胞毒性検査売上予測2017-2028 - 細胞毒性検査の地域別販売量 - 細胞毒性検査の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別細胞毒性検査販売量 - 主要メーカー別細胞毒性検査売上 - 主要メーカー別細胞毒性検査価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（溶出検査法、寒天オーバーレイ法、ダイレクトコンタクト法、MTTアッセイ法、その他） - 細胞毒性検査のタイプ別販売量 - 細胞毒性検査のタイプ別売上 - 細胞毒性検査のタイプ別価格 ・アプリケーション別市場規模（医療機器、医療用付属品、その他） - 細胞毒性検査のアプリケーション別販売量 - 細胞毒性検査のアプリケーション別売上 - 細胞毒性検査のアプリケーション別価格 ・北米市場 - 北米の細胞毒性検査市場規模（タイプ別、アプリケーション別） - 主要国別の細胞毒性検査市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの細胞毒性検査市場規模（タイプ別、アプリケーション別） - 主要国別の細胞毒性検査市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の細胞毒性検査市場規模（タイプ別、アプリケーション別） - 主要国別の細胞毒性検査市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の細胞毒性検査市場規模（タイプ別、アプリケーション別） - 主要国別の細胞毒性検査市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの細胞毒性検査市場規模（タイプ別、アプリケーション別） - 主要国別の細胞毒性検査市場規模（トルコ、サウジアラビア） ・企業情報 Sartorius、UL、Eurofins、SGS、Emery Pharma、Nelson Labs、UFAG Laboratorien AG、Pacific BioLabs、NorthEast BioLab、Biosafe Ltd、Creative Bioarray、Evercyte、IONTOX、Applied StemCell、Xenometrix AG、TÜV SÜD、Medicilon、Huatongwei ・産業チェーン及び販売チャネル分析 - 細胞毒性検査の産業チェーン分析 - 細胞毒性検査の原材料 - 細胞毒性検査の生産プロセス - 細胞毒性検査の販売及びマーケティング - 細胞毒性検査の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 細胞毒性検査の産業動向 - 細胞毒性検査のマーケットドライバー - 細胞毒性検査の課題 - 細胞毒性検査の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Cytotoxicity Testing estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Cytotoxicity Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Cytotoxicity Testing include Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Cytotoxicity Testing companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Cytotoxicity Testing market. Further, it explains the major drivers and regional dynamics of the global Cytotoxicity Testing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Sartorius
UL
Eurofins
SGS
Emery Pharma
Nelson Labs
UFAG Laboratorien AG
Pacific BioLabs
NorthEast BioLab
Biosafe Ltd
Creative Bioarray
Evercyte
IONTOX
Applied StemCell
Xenometrix AG
TÜV SÜD
Medicilon
Huatongwei
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Cytotoxicity Testing Segment by Type
Elution Testing Method
Agar Overlay Method
Direct Contact Method
MTT Assay Method
Others
Cytotoxicity Testing Segment by Application
Medical Device
Medical Accessories
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Cytotoxicity Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Cytotoxicity Testing market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Cytotoxicity Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Cytotoxicity Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Cytotoxicity Testing revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Cytotoxicity Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Cytotoxicity Testing revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Sartorius, UL, Eurofins, SGS, Emery Pharma, Nelson Labs, UFAG Laboratorien AG, Pacific BioLabs and NorthEast BioLab, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Cytotoxicity Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cytotoxicity Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cytotoxicity Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cytotoxicity Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Elution Testing Method
1.2.3 Agar Overlay Method
1.2.4 Direct Contact Method
1.2.5 MTT Assay Method
1.2.6 Others
1.3 Market by Application
1.3.1 Global Cytotoxicity Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Medical Device
1.3.3 Medical Accessories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cytotoxicity Testing Market Perspective (2017-2028)
2.2 Cytotoxicity Testing Growth Trends by Region
2.2.1 Cytotoxicity Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cytotoxicity Testing Historic Market Size by Region (2017-2022)
2.2.3 Cytotoxicity Testing Forecasted Market Size by Region (2023-2028)
2.3 Cytotoxicity Testing Market Dynamics
2.3.1 Cytotoxicity Testing Industry Trends
2.3.2 Cytotoxicity Testing Market Drivers
2.3.3 Cytotoxicity Testing Market Challenges
2.3.4 Cytotoxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cytotoxicity Testing Players by Revenue
3.1.1 Global Top Cytotoxicity Testing Players by Revenue (2017-2022)
3.1.2 Global Cytotoxicity Testing Revenue Market Share by Players (2017-2022)
3.2 Global Cytotoxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cytotoxicity Testing Revenue
3.4 Global Cytotoxicity Testing Market Concentration Ratio
3.4.1 Global Cytotoxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cytotoxicity Testing Revenue in 2021
3.5 Cytotoxicity Testing Key Players Head office and Area Served
3.6 Key Players Cytotoxicity Testing Product Solution and Service
3.7 Date of Enter into Cytotoxicity Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cytotoxicity Testing Breakdown Data by Type
4.1 Global Cytotoxicity Testing Historic Market Size by Type (2017-2022)
4.2 Global Cytotoxicity Testing Forecasted Market Size by Type (2023-2028)
5 Cytotoxicity Testing Breakdown Data by Application
5.1 Global Cytotoxicity Testing Historic Market Size by Application (2017-2022)
5.2 Global Cytotoxicity Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cytotoxicity Testing Market Size (2017-2028)
6.2 North America Cytotoxicity Testing Market Size by Type
6.2.1 North America Cytotoxicity Testing Market Size by Type (2017-2022)
6.2.2 North America Cytotoxicity Testing Market Size by Type (2023-2028)
6.2.3 North America Cytotoxicity Testing Market Share by Type (2017-2028)
6.3 North America Cytotoxicity Testing Market Size by Application
6.3.1 North America Cytotoxicity Testing Market Size by Application (2017-2022)
6.3.2 North America Cytotoxicity Testing Market Size by Application (2023-2028)
6.3.3 North America Cytotoxicity Testing Market Share by Application (2017-2028)
6.4 North America Cytotoxicity Testing Market Size by Country
6.4.1 North America Cytotoxicity Testing Market Size by Country (2017-2022)
6.4.2 North America Cytotoxicity Testing Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Cytotoxicity Testing Market Size (2017-2028)
7.2 Europe Cytotoxicity Testing Market Size by Type
7.2.1 Europe Cytotoxicity Testing Market Size by Type (2017-2022)
7.2.2 Europe Cytotoxicity Testing Market Size by Type (2023-2028)
7.2.3 Europe Cytotoxicity Testing Market Share by Type (2017-2028)
7.3 Europe Cytotoxicity Testing Market Size by Application
7.3.1 Europe Cytotoxicity Testing Market Size by Application (2017-2022)
7.3.2 Europe Cytotoxicity Testing Market Size by Application (2023-2028)
7.3.3 Europe Cytotoxicity Testing Market Share by Application (2017-2028)
7.4 Europe Cytotoxicity Testing Market Size by Country
7.4.1 Europe Cytotoxicity Testing Market Size by Country (2017-2022)
7.4.2 Europe Cytotoxicity Testing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cytotoxicity Testing Market Size (2017-2028)
8.2 Asia-Pacific Cytotoxicity Testing Market Size by Type
8.2.1 Asia-Pacific Cytotoxicity Testing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cytotoxicity Testing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cytotoxicity Testing Market Share by Type (2017-2028)
8.3 Asia-Pacific Cytotoxicity Testing Market Size by Application
8.3.1 Asia-Pacific Cytotoxicity Testing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cytotoxicity Testing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cytotoxicity Testing Market Share by Application (2017-2028)
8.4 Asia-Pacific Cytotoxicity Testing Market Size by Region
8.4.1 Asia-Pacific Cytotoxicity Testing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cytotoxicity Testing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cytotoxicity Testing Market Size (2017-2028)
9.2 Latin America Cytotoxicity Testing Market Size by Type
9.2.1 Latin America Cytotoxicity Testing Market Size by Type (2017-2022)
9.2.2 Latin America Cytotoxicity Testing Market Size by Type (2023-2028)
9.2.3 Latin America Cytotoxicity Testing Market Share by Type (2017-2028)
9.3 Latin America Cytotoxicity Testing Market Size by Application
9.3.1 Latin America Cytotoxicity Testing Market Size by Application (2017-2022)
9.3.2 Latin America Cytotoxicity Testing Market Size by Application (2023-2028)
9.3.3 Latin America Cytotoxicity Testing Market Share by Application (2017-2028)
9.4 Latin America Cytotoxicity Testing Market Size by Country
9.4.1 Latin America Cytotoxicity Testing Market Size by Country (2017-2022)
9.4.2 Latin America Cytotoxicity Testing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cytotoxicity Testing Market Size (2017-2028)
10.2 Middle East & Africa Cytotoxicity Testing Market Size by Type
10.2.1 Middle East & Africa Cytotoxicity Testing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cytotoxicity Testing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cytotoxicity Testing Market Share by Type (2017-2028)
10.3 Middle East & Africa Cytotoxicity Testing Market Size by Application
10.3.1 Middle East & Africa Cytotoxicity Testing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cytotoxicity Testing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cytotoxicity Testing Market Share by Application (2017-2028)
10.4 Middle East & Africa Cytotoxicity Testing Market Size by Country
10.4.1 Middle East & Africa Cytotoxicity Testing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cytotoxicity Testing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sartorius
11.1.1 Sartorius Company Details
11.1.2 Sartorius Business Overview
11.1.3 Sartorius Cytotoxicity Testing Introduction
11.1.4 Sartorius Revenue in Cytotoxicity Testing Business (2017-2022)
11.1.5 Sartorius Recent Developments
11.2 UL
11.2.1 UL Company Details
11.2.2 UL Business Overview
11.2.3 UL Cytotoxicity Testing Introduction
11.2.4 UL Revenue in Cytotoxicity Testing Business (2017-2022)
11.2.5 UL Recent Developments
11.3 Eurofins
11.3.1 Eurofins Company Details
11.3.2 Eurofins Business Overview
11.3.3 Eurofins Cytotoxicity Testing Introduction
11.3.4 Eurofins Revenue in Cytotoxicity Testing Business (2017-2022)
11.3.5 Eurofins Recent Developments
11.4 SGS
11.4.1 SGS Company Details
11.4.2 SGS Business Overview
11.4.3 SGS Cytotoxicity Testing Introduction
11.4.4 SGS Revenue in Cytotoxicity Testing Business (2017-2022)
11.4.5 SGS Recent Developments
11.5 Emery Pharma
11.5.1 Emery Pharma Company Details
11.5.2 Emery Pharma Business Overview
11.5.3 Emery Pharma Cytotoxicity Testing Introduction
11.5.4 Emery Pharma Revenue in Cytotoxicity Testing Business (2017-2022)
11.5.5 Emery Pharma Recent Developments
11.6 Nelson Labs
11.6.1 Nelson Labs Company Details
11.6.2 Nelson Labs Business Overview
11.6.3 Nelson Labs Cytotoxicity Testing Introduction
11.6.4 Nelson Labs Revenue in Cytotoxicity Testing Business (2017-2022)
11.6.5 Nelson Labs Recent Developments
11.7 UFAG Laboratorien AG
11.7.1 UFAG Laboratorien AG Company Details
11.7.2 UFAG Laboratorien AG Business Overview
11.7.3 UFAG Laboratorien AG Cytotoxicity Testing Introduction
11.7.4 UFAG Laboratorien AG Revenue in Cytotoxicity Testing Business (2017-2022)
11.7.5 UFAG Laboratorien AG Recent Developments
11.8 Pacific BioLabs
11.8.1 Pacific BioLabs Company Details
11.8.2 Pacific BioLabs Business Overview
11.8.3 Pacific BioLabs Cytotoxicity Testing Introduction
11.8.4 Pacific BioLabs Revenue in Cytotoxicity Testing Business (2017-2022)
11.8.5 Pacific BioLabs Recent Developments
11.9 NorthEast BioLab
11.9.1 NorthEast BioLab Company Details
11.9.2 NorthEast BioLab Business Overview
11.9.3 NorthEast BioLab Cytotoxicity Testing Introduction
11.9.4 NorthEast BioLab Revenue in Cytotoxicity Testing Business (2017-2022)
11.9.5 NorthEast BioLab Recent Developments
11.10 Biosafe Ltd
11.10.1 Biosafe Ltd Company Details
11.10.2 Biosafe Ltd Business Overview
11.10.3 Biosafe Ltd Cytotoxicity Testing Introduction
11.10.4 Biosafe Ltd Revenue in Cytotoxicity Testing Business (2017-2022)
11.10.5 Biosafe Ltd Recent Developments
11.11 Creative Bioarray
11.11.1 Creative Bioarray Company Details
11.11.2 Creative Bioarray Business Overview
11.11.3 Creative Bioarray Cytotoxicity Testing Introduction
11.11.4 Creative Bioarray Revenue in Cytotoxicity Testing Business (2017-2022)
11.11.5 Creative Bioarray Recent Developments
11.12 Evercyte
11.12.1 Evercyte Company Details
11.12.2 Evercyte Business Overview
11.12.3 Evercyte Cytotoxicity Testing Introduction
11.12.4 Evercyte Revenue in Cytotoxicity Testing Business (2017-2022)
11.12.5 Evercyte Recent Developments
11.13 IONTOX
11.13.1 IONTOX Company Details
11.13.2 IONTOX Business Overview
11.13.3 IONTOX Cytotoxicity Testing Introduction
11.13.4 IONTOX Revenue in Cytotoxicity Testing Business (2017-2022)
11.13.5 IONTOX Recent Developments
11.14 Applied StemCell
11.14.1 Applied StemCell Company Details
11.14.2 Applied StemCell Business Overview
11.14.3 Applied StemCell Cytotoxicity Testing Introduction
11.14.4 Applied StemCell Revenue in Cytotoxicity Testing Business (2017-2022)
11.14.5 Applied StemCell Recent Developments
11.15 Xenometrix AG
11.15.1 Xenometrix AG Company Details
11.15.2 Xenometrix AG Business Overview
11.15.3 Xenometrix AG Cytotoxicity Testing Introduction
11.15.4 Xenometrix AG Revenue in Cytotoxicity Testing Business (2017-2022)
11.15.5 Xenometrix AG Recent Developments
11.16 TÜV SÜD
11.16.1 TÜV SÜD Company Details
11.16.2 TÜV SÜD Business Overview
11.16.3 TÜV SÜD Cytotoxicity Testing Introduction
11.16.4 TÜV SÜD Revenue in Cytotoxicity Testing Business (2017-2022)
11.16.5 TÜV SÜD Recent Developments
11.17 Medicilon
11.17.1 Medicilon Company Details
11.17.2 Medicilon Business Overview
11.17.3 Medicilon Cytotoxicity Testing Introduction
11.17.4 Medicilon Revenue in Cytotoxicity Testing Business (2017-2022)
11.17.5 Medicilon Recent Developments
11.18 Huatongwei
11.18.1 Huatongwei Company Details
11.18.2 Huatongwei Business Overview
11.18.3 Huatongwei Cytotoxicity Testing Introduction
11.18.4 Huatongwei Revenue in Cytotoxicity Testing Business (2017-2022)
11.18.5 Huatongwei Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer